Wyntide 1mg/ml Pen 1S

About: Wyntide 1mg/ml Pen contains Semaglutide, a GLP-1 receptor agonist for type 2 diabetes and weight management in once-weekly injection.Usage Instructions: Inject subcutaneously once weekly on same day each week. Rotate injection sites (abdomen, thigh, upper arm). Can be taken with or without food.Benefits: Improves glycemic control, promotes significant weight loss, reduces cardiovascular risk, once-weekly dosing, low hypoglycemia risk.How it Works: Semaglutide mimics GLP-1 hormone, enhancing glucose-dependent insulin secretion, suppressing glucagon, slowing gastric emptying, reducing appetite.Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, injection site reactions. Serious: pancreatitis, gallbladder disease, kidney problems.Safety Advice: Not for type 1 diabetes or DKA. Contraindicated in personal/family history of medullary thyroid carcinoma or MEN 2. Monitor for pancreatitis symptoms. Use caution in renal impairment.Storage: Refrigerate at 2-8°C. Do not freeze. After first use, can store at room temperature (below 30°C) for up to 6 weeks. Protect from light.